» Articles » PMID: 37935659

Targeting Nucleic Acid Phase Transitions As a Mechanism of Action for Antimicrobial Peptides

Abstract

Antimicrobial peptides (AMPs), which combat bacterial infections by disrupting the bacterial cell membrane or interacting with intracellular targets, are naturally produced by a number of different organisms, and are increasingly also explored as therapeutics. However, the mechanisms by which AMPs act on intracellular targets are not well understood. Using machine learning-based sequence analysis, we identified a significant number of AMPs that have a strong tendency to form liquid-like condensates in the presence of nucleic acids through phase separation. We demonstrate that this phase separation propensity is linked to the effectiveness of the AMPs in inhibiting transcription and translation in vitro, as well as their ability to compact nucleic acids and form clusters with bacterial nucleic acids in bacterial cells. These results suggest that the AMP-driven compaction of nucleic acids and modulation of their phase transitions constitute a previously unrecognised mechanism by which AMPs exert their antibacterial effects. The development of antimicrobials that target nucleic acid phase transitions may become an attractive route to finding effective and long-lasting antibiotics.

Citing Articles

Explainable deep learning and virtual evolution identifies antimicrobial peptides with activity against multidrug-resistant human pathogens.

Wang B, Lin P, Zhong Y, Tan X, Shen Y, Huang Y Nat Microbiol. 2025; 10(2):332-347.

PMID: 39825096 DOI: 10.1038/s41564-024-01907-3.


Antimicrobial neuropeptides and their therapeutic potential in vertebrate brain infectious disease.

Li X, Chen K, Liu R, Zheng Z, Hou X Front Immunol. 2024; 15:1496147.

PMID: 39620214 PMC: 11604648. DOI: 10.3389/fimmu.2024.1496147.


Chemically diverse antimicrobial peptides induce hyperpolarization of the E. coli membrane.

Bhaumik K, Spohn R, Dunai A, Daruka L, Olajos G, Zakany F Commun Biol. 2024; 7(1):1264.

PMID: 39367191 PMC: 11452689. DOI: 10.1038/s42003-024-06946-4.


Cell-Free Systems: Ideal Platforms for Accelerating the Discovery and Production of Peptide-Based Antibiotics.

Park H, Jin H, Kim D, Lee J Int J Mol Sci. 2024; 25(16).

PMID: 39201795 PMC: 11354240. DOI: 10.3390/ijms25169109.


Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.

Tajer L, Paillart J, Dib H, Sabatier J, Fajloun Z, Khattar Z Microorganisms. 2024; 12(7).

PMID: 39065030 PMC: 11279074. DOI: 10.3390/microorganisms12071259.


References
1.
El Shazely B, Yu G, Johnston P, Rolff J . Resistance Evolution Against Antimicrobial Peptides in Alters Pharmacodynamics Beyond the MIC. Front Microbiol. 2020; 11:103. PMC: 7033599. DOI: 10.3389/fmicb.2020.00103. View

2.
Al-Husini N, Tomares D, Pfaffenberger Z, Muthunayake N, Samad M, Zuo T . BR-Bodies Provide Selectively Permeable Condensates that Stimulate mRNA Decay and Prevent Release of Decay Intermediates. Mol Cell. 2020; 78(4):670-682.e8. PMC: 7245546. DOI: 10.1016/j.molcel.2020.04.001. View

3.
Borodavka A, Dykeman E, Schrimpf W, Lamb D . Protein-mediated RNA folding governs sequence-specific interactions between rotavirus genome segments. Elife. 2017; 6. PMC: 5621836. DOI: 10.7554/eLife.27453. View

4.
Zhang Q, Yan Z, Meng Y, Hong X, Shao G, Ma J . Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021; 8(1):48. PMC: 8425997. DOI: 10.1186/s40779-021-00343-2. View

5.
Frieri M, Kumar K, Boutin A . Antibiotic resistance. J Infect Public Health. 2016; 10(4):369-378. DOI: 10.1016/j.jiph.2016.08.007. View